Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma, Synovial × Idarubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 70 Leukemia 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Leukemia, Myelomonocytic, Acute 16 Leukemia, Monocytic, Acute 16 Leukemia, Megakaryoblastic, Acute 14 Leukemia, Erythroblastic, Acute 14 Congenital Abnormalities 14 Myelodysplastic Syndromes 10 Leukemia, Promyelocytic, Acute 7 Leukemia, Myelomonocytic, Chronic 7 Anemia, Refractory, with Excess of Blasts 7 Recurrence 6 Myeloproliferative Disorders 5 Leukemia, Eosinophilic, Acute 5 Leukemia, Basophilic, Acute 4 Leukemia, Myeloid, Chronic-Phase 3 Blast Crisis 3 Neutropenia 2 Neoplasms 2 Lymphoma 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Carcinoma, Hepatocellular 2 Thrombocythemia, Essential 1 Sarcoma, Synovial 1 Sarcoma 1 Rhabdomyosarcoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1

Interventions

Doxorubicin 11 Ifosfamide 9 Radiotherapy 6 tazemetostat 4 pegfilgrastim 3 cixutumumab 3 Imatinib Mesylate 3 Filgrastim 3 Cyclophosphamide 3 pazopanib 2 Trabectedin 2 Sunitinib 2 Sorafenib 2 Etoposide 2 Dacarbazine 2 Chemotherapy, Adjuvant 2 trofosfamide 1 tremelimumab 1 temsirolimus 1 soblidotin 1 sargramostim 1 romidepsin 1 ribociclib 1 reolysin 1 poly ICLC 1 perifosine 1 pembrolizumab 1 lorvotuzumab mertansine 1 liposomal doxorubicin 1 ixabepilone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡